Detalhe da pesquisa
1.
Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report.
JTO Clin Res Rep
; 5(2): 100631, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38322711
2.
Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis.
Anticancer Res
; 41(10): 5137-5145, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34593465
3.
Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice.
Int J Cardiol
; 313: 67-75, 2020 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32402518
4.
PD-L1 expression in neuroendocrine tumors of the lung.
Lung Cancer
; 108: 115-120, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28625622
5.
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
BMC Res Notes
; 8: 800, 2015 Dec 18.
Artigo
Inglês
| MEDLINE | ID: mdl-26682906